Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

57.47
+0.47000.82%
Volume:2.56M
Turnover:146.36M
Market Cap:116.99B
PE:16.61
High:57.55
Open:56.83
Low:56.46
Close:57.00
52wk High:62.89
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.30
T/O Rate:0.13%
Dividend:2.49
Dividend Rate:4.33%
EPS(TTM):3.46
EPS(LYR):3.46
ROE:40.44%
ROA:10.29%
PB:6.33
PE(LYR):16.61

Loading ...

Balanced Risk-Reward Keeps Bristol-Myers Squibb Rated Hold as CELMoD Franchise Awaits Key Iberdomide Data

TIPRANKS
·
Feb 17

FDA Accepts Bristol Myers Squibb Application for Iberdomide in Multiple Myeloma

Reuters
·
Feb 17

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS
·
Feb 17

Bristol-Myers Squibb Co - FDA Assigns Pdufa Date of August 17, 2026

THOMSON REUTERS
·
Feb 17

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 14

Bristol Myers’ treatment of follicular lymphoma granted FDA orphan designation

TIPRANKS
·
Feb 14

BMY-Backed Milvexian Stroke Trial Moves Forward, Keeping Upside Optionality Alive

TIPRANKS
·
Feb 14

Bristol-Myers Squibb Expands Real-World MDS Footprint in Asia With New Registry Study

TIPRANKS
·
Feb 14

Bristol-Myers Squibb: Solid Near-Term Execution and 2026 EPS Boost from Eliquis, but Limited Long-Term Visibility Supports Hold Rating

TIPRANKS
·
Feb 10

AstraZeneca Signs Global Rights Agreement With CSPC for Injectable Weight Management Portfolio

Reuters
·
Feb 10

Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Feb 10

Bristol-Myers Squibb Is Maintained at Buy by Guggenheim

Dow Jones
·
Feb 06

BUZZ-Street View: Bristol Myers Squibb drug pipeline in focus as key patent expiry looms

Reuters
·
Feb 06

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Resmed (RMD) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Feb 06

Bristol-Myers Squibb Company : Wells Fargo Raises Target Price to $60 From $55

THOMSON REUTERS
·
Feb 06

Bristol-Myers Squibb Co : Citigroup Raises Target Price to $64 From $60

THOMSON REUTERS
·
Feb 06

Bristol-Myers Squibb Co : Morgan Stanley Raises Target Price to $40 From $37

THOMSON REUTERS
·
Feb 06

U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren

Reuters
·
Feb 06

Reiterating Buy on Bristol-Myers Squibb: Milvexian’s Validated FXIa Mechanism and Underappreciated Stroke Prevention Upside Support $65 Target

TIPRANKS
·
Feb 06

Truist incrementally positive on Bristol Myers after Bayer asundexian data

TIPRANKS
·
Feb 06